|Articles|February 18, 2018
New Potential Way to Combat Influenza Highlights AJPB Week in Review
Author(s)AJPB staff
Top articles of the week from The American Journal of Pharmacy Benefits.
Advertisement
5. Migraines May Be Key Risk Factor for Cardiovascular Diseases
In addition to myocardial infarction and stroke, migraines may also be linked to an increased risk for venous thromboembolism and atrial fibrillation.
4. Threat of Drug-Resistant E. Coli Increases with Pediatric Antibiotic Prescriptions
Antibiotics may become ineffective treating E. Coli if antibiotic resistance continues to increase among children.
3. Experimental Drug Fails in Alzheimer's Disease Trial
An investigational PDE9A inhibitor did not show efficacy in patients with Alzheimer’s disease.
2. Influenza Vaccine More Effective Than Previously Projected
The 2017/2018 influenza vaccine was more effective in the United States than Canada and Australia.
1. UV Light Could Fight the Spread of Influenza
Ultraviolet C light could be safely harnessed to kill influenza microbes.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices
2
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
3
FDA Approves Lumateperone With Antidepressant Use for Major Depressive Disorder
4
Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health
5
